nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—Alopecia reversible—Mesalazine—Crohn's disease	0.0637	0.112	CcSEcCtD
Albendazole—TUBA1A—gall bladder—Crohn's disease	0.0521	0.121	CbGeAlD
Albendazole—TUBA1A—mouth—Crohn's disease	0.0463	0.108	CbGeAlD
Albendazole—TUBA1A—epithelium—Crohn's disease	0.0269	0.0627	CbGeAlD
Albendazole—TUBA1A—smooth muscle tissue—Crohn's disease	0.026	0.0604	CbGeAlD
Albendazole—TUBA1A—skin of body—Crohn's disease	0.0256	0.0597	CbGeAlD
Albendazole—TUBA1A—mammalian vulva—Crohn's disease	0.0234	0.0544	CbGeAlD
Albendazole—TUBA1A—lymphoid tissue—Crohn's disease	0.0208	0.0483	CbGeAlD
Albendazole—TUBA1A—digestive system—Crohn's disease	0.0205	0.0477	CbGeAlD
Albendazole—Intracranial pressure increased—Prednisone—Crohn's disease	0.0183	0.0321	CcSEcCtD
Albendazole—TUBB4B—smooth muscle tissue—Crohn's disease	0.0173	0.0403	CbGeAlD
Albendazole—CYP1A1—mouth—Crohn's disease	0.0173	0.0402	CbGeAlD
Albendazole—TUBB4B—skin of body—Crohn's disease	0.0171	0.0398	CbGeAlD
Albendazole—Pancytopenia—Mercaptopurine—Crohn's disease	0.0159	0.0278	CcSEcCtD
Albendazole—TUBB4B—mammalian vulva—Crohn's disease	0.0156	0.0363	CbGeAlD
Albendazole—Aplastic anaemia—Azathioprine—Crohn's disease	0.0149	0.0261	CcSEcCtD
Albendazole—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0141	0.0247	CcSEcCtD
Albendazole—TUBB4B—lymphoid tissue—Crohn's disease	0.0138	0.0322	CbGeAlD
Albendazole—TUBB4B—digestive system—Crohn's disease	0.0137	0.0318	CbGeAlD
Albendazole—Aplastic anaemia—Mesalazine—Crohn's disease	0.0136	0.0238	CcSEcCtD
Albendazole—Immune system disorder—Mercaptopurine—Crohn's disease	0.0121	0.0212	CcSEcCtD
Albendazole—Alopecia—Mercaptopurine—Crohn's disease	0.0118	0.0207	CcSEcCtD
Albendazole—TUBA1A—lymph node—Crohn's disease	0.0117	0.0273	CbGeAlD
Albendazole—Renal failure acute—Mesalazine—Crohn's disease	0.0114	0.0199	CcSEcCtD
Albendazole—Leukopenia—Mercaptopurine—Crohn's disease	0.0104	0.0183	CcSEcCtD
Albendazole—CYP1A1—epithelium—Crohn's disease	0.0101	0.0234	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00984	0.0173	CcSEcCtD
Albendazole—Liver function test abnormal—Mesalazine—Crohn's disease	0.00969	0.017	CcSEcCtD
Albendazole—CYP1A1—skin of body—Crohn's disease	0.00956	0.0223	CbGeAlD
Albendazole—Pancytopenia—Azathioprine—Crohn's disease	0.00946	0.0166	CcSEcCtD
Albendazole—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.0093	0.0163	CcSEcCtD
Albendazole—Skin disorder—Mercaptopurine—Crohn's disease	0.00923	0.0162	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0088	0.0154	CcSEcCtD
Albendazole—CYP1A1—mammalian vulva—Crohn's disease	0.00872	0.0203	CbGeAlD
Albendazole—Pancytopenia—Mesalazine—Crohn's disease	0.00861	0.0151	CcSEcCtD
Albendazole—Neutropenia—Mesalazine—Crohn's disease	0.00848	0.0149	CcSEcCtD
Albendazole—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0084	0.0147	CcSEcCtD
Albendazole—Agranulocytosis—Azathioprine—Crohn's disease	0.00828	0.0145	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00802	0.0141	CcSEcCtD
Albendazole—TUBB4B—lymph node—Crohn's disease	0.0078	0.0182	CbGeAlD
Albendazole—CYP1A2—digestive system—Crohn's disease	0.00776	0.0181	CbGeAlD
Albendazole—CYP1A1—digestive system—Crohn's disease	0.00765	0.0178	CbGeAlD
Albendazole—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00765	0.0134	CcSEcCtD
Albendazole—Agranulocytosis—Mesalazine—Crohn's disease	0.00755	0.0132	CcSEcCtD
Albendazole—Erythema multiforme—Azathioprine—Crohn's disease	0.00754	0.0132	CcSEcCtD
Albendazole—Body temperature increased—Mercaptopurine—Crohn's disease	0.00751	0.0132	CcSEcCtD
Albendazole—Hepatitis—Mesalazine—Crohn's disease	0.00726	0.0127	CcSEcCtD
Albendazole—Immune system disorder—Azathioprine—Crohn's disease	0.0072	0.0126	CcSEcCtD
Albendazole—Urinary tract disorder—Mesalazine—Crohn's disease	0.00717	0.0126	CcSEcCtD
Albendazole—Urethral disorder—Mesalazine—Crohn's disease	0.00712	0.0125	CcSEcCtD
Albendazole—Alopecia—Azathioprine—Crohn's disease	0.00704	0.0123	CcSEcCtD
Albendazole—Hypersensitivity—Mercaptopurine—Crohn's disease	0.007	0.0123	CcSEcCtD
Albendazole—Erythema multiforme—Mesalazine—Crohn's disease	0.00686	0.012	CcSEcCtD
Albendazole—Immune system disorder—Mesalazine—Crohn's disease	0.00656	0.0115	CcSEcCtD
Albendazole—Alopecia—Mesalazine—Crohn's disease	0.00641	0.0112	CcSEcCtD
Albendazole—Leukopenia—Azathioprine—Crohn's disease	0.00621	0.0109	CcSEcCtD
Albendazole—Vomiting—Mercaptopurine—Crohn's disease	0.00604	0.0106	CcSEcCtD
Albendazole—Rash—Mercaptopurine—Crohn's disease	0.00599	0.0105	CcSEcCtD
Albendazole—Dermatitis—Mercaptopurine—Crohn's disease	0.00599	0.0105	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00587	0.0103	CcSEcCtD
Albendazole—Vertigo—Mesalazine—Crohn's disease	0.00568	0.00995	CcSEcCtD
Albendazole—Leukopenia—Mesalazine—Crohn's disease	0.00566	0.00992	CcSEcCtD
Albendazole—Nausea—Mercaptopurine—Crohn's disease	0.00564	0.0099	CcSEcCtD
Albendazole—CYP3A4—digestive system—Crohn's disease	0.00561	0.0131	CbGeAlD
Albendazole—Thrombocytopenia—Azathioprine—Crohn's disease	0.00554	0.00972	CcSEcCtD
Albendazole—Skin disorder—Azathioprine—Crohn's disease	0.0055	0.00964	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00534	0.00937	CcSEcCtD
Albendazole—ABCB1—epithelium—Crohn's disease	0.00522	0.0122	CbGeAlD
Albendazole—Thrombocytopenia—Mesalazine—Crohn's disease	0.00505	0.00885	CcSEcCtD
Albendazole—Skin disorder—Mesalazine—Crohn's disease	0.00501	0.00878	CcSEcCtD
Albendazole—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00463	0.00812	CcSEcCtD
Albendazole—ABCB1—mammalian vulva—Crohn's disease	0.00453	0.0105	CbGeAlD
Albendazole—Neutropenia—Prednisone—Crohn's disease	0.00449	0.00787	CcSEcCtD
Albendazole—Abdominal pain—Azathioprine—Crohn's disease	0.00448	0.00785	CcSEcCtD
Albendazole—Body temperature increased—Azathioprine—Crohn's disease	0.00448	0.00785	CcSEcCtD
Albendazole—CYP1A1—lymph node—Crohn's disease	0.00437	0.0102	CbGeAlD
Albendazole—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00422	0.00739	CcSEcCtD
Albendazole—Hypersensitivity—Azathioprine—Crohn's disease	0.00417	0.00731	CcSEcCtD
Albendazole—Urticaria—Mesalazine—Crohn's disease	0.0041	0.00718	CcSEcCtD
Albendazole—Body temperature increased—Mesalazine—Crohn's disease	0.00408	0.00715	CcSEcCtD
Albendazole—Abdominal pain—Mesalazine—Crohn's disease	0.00408	0.00715	CcSEcCtD
Albendazole—ABCB1—lymphoid tissue—Crohn's disease	0.00402	0.00936	CbGeAlD
Albendazole—ABCB1—digestive system—Crohn's disease	0.00397	0.00925	CbGeAlD
Albendazole—Hypersensitivity—Mesalazine—Crohn's disease	0.0038	0.00666	CcSEcCtD
Albendazole—Dizziness—Azathioprine—Crohn's disease	0.00374	0.00656	CcSEcCtD
Albendazole—Vomiting—Azathioprine—Crohn's disease	0.0036	0.00631	CcSEcCtD
Albendazole—Rash—Azathioprine—Crohn's disease	0.00357	0.00626	CcSEcCtD
Albendazole—Dermatitis—Azathioprine—Crohn's disease	0.00357	0.00625	CcSEcCtD
Albendazole—Headache—Azathioprine—Crohn's disease	0.00355	0.00622	CcSEcCtD
Albendazole—Immune system disorder—Prednisone—Crohn's disease	0.00347	0.00608	CcSEcCtD
Albendazole—Dizziness—Mesalazine—Crohn's disease	0.00341	0.00598	CcSEcCtD
Albendazole—Alopecia—Prednisone—Crohn's disease	0.00339	0.00595	CcSEcCtD
Albendazole—Nausea—Azathioprine—Crohn's disease	0.00336	0.0059	CcSEcCtD
Albendazole—Vomiting—Mesalazine—Crohn's disease	0.00328	0.00575	CcSEcCtD
Albendazole—Rash—Mesalazine—Crohn's disease	0.00325	0.0057	CcSEcCtD
Albendazole—Dermatitis—Mesalazine—Crohn's disease	0.00325	0.0057	CcSEcCtD
Albendazole—Headache—Mesalazine—Crohn's disease	0.00323	0.00567	CcSEcCtD
Albendazole—Nausea—Mesalazine—Crohn's disease	0.00306	0.00537	CcSEcCtD
Albendazole—Vertigo—Prednisone—Crohn's disease	0.003	0.00527	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00283	0.00496	CcSEcCtD
Albendazole—Skin disorder—Prednisone—Crohn's disease	0.00265	0.00465	CcSEcCtD
Albendazole—ABCB1—lymph node—Crohn's disease	0.00227	0.00528	CbGeAlD
Albendazole—Gastrointestinal pain—Prednisone—Crohn's disease	0.00223	0.00391	CcSEcCtD
Albendazole—Urticaria—Prednisone—Crohn's disease	0.00217	0.0038	CcSEcCtD
Albendazole—Abdominal pain—Prednisone—Crohn's disease	0.00216	0.00378	CcSEcCtD
Albendazole—Body temperature increased—Prednisone—Crohn's disease	0.00216	0.00378	CcSEcCtD
Albendazole—Hypersensitivity—Prednisone—Crohn's disease	0.00201	0.00353	CcSEcCtD
Albendazole—Dizziness—Prednisone—Crohn's disease	0.0018	0.00316	CcSEcCtD
Albendazole—Vomiting—Prednisone—Crohn's disease	0.00174	0.00304	CcSEcCtD
Albendazole—Rash—Prednisone—Crohn's disease	0.00172	0.00302	CcSEcCtD
Albendazole—Dermatitis—Prednisone—Crohn's disease	0.00172	0.00301	CcSEcCtD
Albendazole—Headache—Prednisone—Crohn's disease	0.00171	0.003	CcSEcCtD
Albendazole—Nausea—Prednisone—Crohn's disease	0.00162	0.00284	CcSEcCtD
